Bio Solution Co.,Ltd. (KOSDAQ:086820)
South Korea · Delayed Price · Currency is KRW 5,910.00
0.00 (0.00%)
At close: Jul 6, 2026
Bio Solution Market Cap
Bio Solution has a market cap or net worth of 152.5 billion as of July 7, 2026. Its market cap has decreased by -43.57% in one year.
Market Cap
152.50B
Enterprise Value
160.77B
Revenue
15.82B
Ranking
n/a
PE Ratio
218.79
Stock Price
5,910.00
Market Cap Chart
Since August 20, 2018, Bio Solution's market cap has decreased from 218.31B to 152.50B, a decrease of -30.14%. That is a compound annual growth rate of -4.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 152.50B | -20.24% |
| Dec 30, 2025 | 191.20B | 10.84% |
| Dec 30, 2024 | 172.51B | 10.88% |
| Dec 28, 2023 | 155.58B | 82.92% |
| Dec 29, 2022 | 85.05B | -50.94% |
| Dec 30, 2021 | 173.35B | -26.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NIBEC | 193.14B |
| Kanaph Therapeutics | 192.34B |
| Y-Biologics | 178.19B |
| Ensol Biosciences | 177.32B |
| Genome & Company | 169.87B |
| Prestige Biologics | 154.73B |
| ISU Abxis | 141.90B |
| TiumBio | 124.81B |